Both membrane and soluble TREM-1 are increased in inflammatory pathologies in humans [15], and inhibition of TREM-1 improves outcome in murine models of sepsis and inflammatory bowel disease [39], [40]. This evidence concerns the gene TREM1 and inflammatory bowel disease.